|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:UBE2C-CDH26 (FusionGDB2 ID:95333) |
Fusion Gene Summary for UBE2C-CDH26 |
Fusion gene summary |
Fusion gene information | Fusion gene name: UBE2C-CDH26 | Fusion gene ID: 95333 | Hgene | Tgene | Gene symbol | UBE2C | CDH26 | Gene ID | 11065 | 60437 |
Gene name | ubiquitin conjugating enzyme E2 C | cadherin 26 | |
Synonyms | UBCH10|dJ447F3.2 | VR20 | |
Cytomap | 20q13.12 | 20q13.33 | |
Type of gene | protein-coding | protein-coding | |
Description | ubiquitin-conjugating enzyme E2 C(E3-independent) E2 ubiquitin-conjugating enzyme CE2 ubiquitin-conjugating enzyme Ccyclin-selective ubiquitin carrier proteinmitotic-specific ubiquitin-conjugating enzymeubiquitin conjugating enzyme E2Cubiquitin-prot | cadherin-like protein 26cadherin-like 26cadherin-like protein VR20 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000356455, ENST00000405520, ENST00000335046, ENST00000243893, ENST00000352551, ENST00000372568, ENST00000496085, | ENST00000244047, ENST00000350849, ENST00000348616, ENST00000497614, ENST00000244049, | |
Fusion gene scores | * DoF score | 8 X 6 X 3=144 | 3 X 4 X 2=24 |
# samples | 8 | 3 | |
** MAII score | log2(8/144*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/24*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: UBE2C [Title/Abstract] AND CDH26 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | UBE2C(44443109)-CDH26(58544022), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | UBE2C | GO:0006511 | ubiquitin-dependent protein catabolic process | 9122200|18485873 |
Hgene | UBE2C | GO:0010994 | free ubiquitin chain polymerization | 19822757 |
Hgene | UBE2C | GO:0016567 | protein ubiquitination | 9122200 |
Hgene | UBE2C | GO:0031145 | anaphase-promoting complex-dependent catabolic process | 9122200|19822757 |
Hgene | UBE2C | GO:0070936 | protein K48-linked ubiquitination | 20061386 |
Hgene | UBE2C | GO:0070979 | protein K11-linked ubiquitination | 18485873|19822757|20061386 |
Tgene | CDH26 | GO:0035710 | CD4-positive, alpha-beta T cell activation | 28051089 |
Fusion gene breakpoints across UBE2C (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across CDH26 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-AN-A0FY-01A | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
ChimerDB4 | BRCA | TCGA-AN-A0FY-01A | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
Top |
Fusion Gene ORF analysis for UBE2C-CDH26 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000356455 | ENST00000244047 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
5CDS-intron | ENST00000356455 | ENST00000350849 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
5CDS-intron | ENST00000356455 | ENST00000348616 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
5CDS-intron | ENST00000356455 | ENST00000497614 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
5CDS-intron | ENST00000356455 | ENST00000244049 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
In-frame | ENST00000405520 | ENST00000244047 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
5CDS-intron | ENST00000405520 | ENST00000350849 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
5CDS-intron | ENST00000405520 | ENST00000348616 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
5CDS-intron | ENST00000405520 | ENST00000497614 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
5CDS-intron | ENST00000405520 | ENST00000244049 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
In-frame | ENST00000335046 | ENST00000244047 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
5CDS-intron | ENST00000335046 | ENST00000350849 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
5CDS-intron | ENST00000335046 | ENST00000348616 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
5CDS-intron | ENST00000335046 | ENST00000497614 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
5CDS-intron | ENST00000335046 | ENST00000244049 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
intron-3CDS | ENST00000243893 | ENST00000244047 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
intron-intron | ENST00000243893 | ENST00000350849 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
intron-intron | ENST00000243893 | ENST00000348616 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
intron-intron | ENST00000243893 | ENST00000497614 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
intron-intron | ENST00000243893 | ENST00000244049 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
intron-3CDS | ENST00000352551 | ENST00000244047 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
intron-intron | ENST00000352551 | ENST00000350849 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
intron-intron | ENST00000352551 | ENST00000348616 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
intron-intron | ENST00000352551 | ENST00000497614 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
intron-intron | ENST00000352551 | ENST00000244049 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
In-frame | ENST00000372568 | ENST00000244047 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
5CDS-intron | ENST00000372568 | ENST00000350849 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
5CDS-intron | ENST00000372568 | ENST00000348616 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
5CDS-intron | ENST00000372568 | ENST00000497614 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
5CDS-intron | ENST00000372568 | ENST00000244049 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
3UTR-3CDS | ENST00000496085 | ENST00000244047 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
3UTR-intron | ENST00000496085 | ENST00000350849 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
3UTR-intron | ENST00000496085 | ENST00000348616 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
3UTR-intron | ENST00000496085 | ENST00000497614 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
3UTR-intron | ENST00000496085 | ENST00000244049 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000356455 | UBE2C | chr20 | 44443109 | + | ENST00000244047 | CDH26 | chr20 | 58544022 | + | 2826 | 336 | 6 | 2825 | 939 |
ENST00000405520 | UBE2C | chr20 | 44443109 | + | ENST00000244047 | CDH26 | chr20 | 58544022 | + | 3426 | 936 | 834 | 3425 | 863 |
ENST00000335046 | UBE2C | chr20 | 44443109 | + | ENST00000244047 | CDH26 | chr20 | 58544022 | + | 2767 | 277 | 7 | 2766 | 920 |
ENST00000372568 | UBE2C | chr20 | 44443109 | + | ENST00000244047 | CDH26 | chr20 | 58544022 | + | 2890 | 400 | 274 | 2889 | 872 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000356455 | ENST00000244047 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + | 0.001067794 | 0.9989322 |
ENST00000405520 | ENST00000244047 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + | 0.001372358 | 0.99862766 |
ENST00000335046 | ENST00000244047 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + | 0.001178167 | 0.9988218 |
ENST00000372568 | ENST00000244047 | UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544022 | + | 0.001157907 | 0.9988422 |
Top |
Fusion Genomic Features for UBE2C-CDH26 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544021 | + | 0.04116962 | 0.9588304 |
UBE2C | chr20 | 44443109 | + | CDH26 | chr20 | 58544021 | + | 0.04116962 | 0.9588304 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for UBE2C-CDH26 |
Go to FGviewer for the breakpoints of chr20:44443109-chr20:58544022 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000244047 | 0 | 17 | 166_275 | 23.0 | 853.0 | Domain | Cadherin 2 | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000244047 | 0 | 17 | 276_396 | 23.0 | 853.0 | Domain | Cadherin 3 | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000244047 | 0 | 17 | 35_165 | 23.0 | 853.0 | Domain | Cadherin 1 | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000244047 | 0 | 17 | 397_500 | 23.0 | 853.0 | Domain | Cadherin 4 | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000244049 | 0 | 4 | 166_275 | 0 | 125.0 | Domain | Cadherin 2 | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000244049 | 0 | 4 | 276_396 | 0 | 125.0 | Domain | Cadherin 3 | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000244049 | 0 | 4 | 35_165 | 0 | 125.0 | Domain | Cadherin 1 | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000244049 | 0 | 4 | 397_500 | 0 | 125.0 | Domain | Cadherin 4 | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000348616 | 0 | 18 | 166_275 | 23.0 | 833.0 | Domain | Cadherin 2 | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000348616 | 0 | 18 | 276_396 | 23.0 | 833.0 | Domain | Cadherin 3 | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000348616 | 0 | 18 | 35_165 | 23.0 | 833.0 | Domain | Cadherin 1 | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000348616 | 0 | 18 | 397_500 | 23.0 | 833.0 | Domain | Cadherin 4 | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000350849 | 0 | 6 | 166_275 | 0 | 166.0 | Domain | Cadherin 2 | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000350849 | 0 | 6 | 276_396 | 0 | 166.0 | Domain | Cadherin 3 | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000350849 | 0 | 6 | 35_165 | 0 | 166.0 | Domain | Cadherin 1 | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000350849 | 0 | 6 | 397_500 | 0 | 166.0 | Domain | Cadherin 4 | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000244047 | 0 | 17 | 28_614 | 23.0 | 853.0 | Topological domain | Extracellular | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000244047 | 0 | 17 | 636_832 | 23.0 | 853.0 | Topological domain | Cytoplasmic | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000244049 | 0 | 4 | 28_614 | 0 | 125.0 | Topological domain | Extracellular | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000244049 | 0 | 4 | 636_832 | 0 | 125.0 | Topological domain | Cytoplasmic | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000348616 | 0 | 18 | 28_614 | 23.0 | 833.0 | Topological domain | Extracellular | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000348616 | 0 | 18 | 636_832 | 23.0 | 833.0 | Topological domain | Cytoplasmic | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000350849 | 0 | 6 | 28_614 | 0 | 166.0 | Topological domain | Extracellular | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000350849 | 0 | 6 | 636_832 | 0 | 166.0 | Topological domain | Cytoplasmic | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000244047 | 0 | 17 | 615_635 | 23.0 | 853.0 | Transmembrane | Helical | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000244049 | 0 | 4 | 615_635 | 0 | 125.0 | Transmembrane | Helical | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000348616 | 0 | 18 | 615_635 | 23.0 | 833.0 | Transmembrane | Helical | |
Tgene | CDH26 | chr20:44443109 | chr20:58544022 | ENST00000350849 | 0 | 6 | 615_635 | 0 | 166.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | UBE2C | chr20:44443109 | chr20:58544022 | ENST00000335046 | + | 3 | 6 | 30_175 | 72.0 | 162.0 | Domain | UBC core |
Hgene | UBE2C | chr20:44443109 | chr20:58544022 | ENST00000352551 | + | 1 | 5 | 30_175 | 0 | 151.0 | Domain | UBC core |
Hgene | UBE2C | chr20:44443109 | chr20:58544022 | ENST00000356455 | + | 3 | 6 | 30_175 | 72.0 | 180.0 | Domain | UBC core |
Hgene | UBE2C | chr20:44443109 | chr20:58544022 | ENST00000372568 | + | 3 | 6 | 30_175 | 33.0 | 141.0 | Domain | UBC core |
Hgene | UBE2C | chr20:44443109 | chr20:58544022 | ENST00000405520 | + | 2 | 5 | 30_175 | 33.0 | 141.0 | Domain | UBC core |
Top |
Fusion Gene Sequence for UBE2C-CDH26 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000356455_ENST00000244047_TCGA-AN-A0FY-01A_UBE2C_chr20_44443109_+_CDH26_chr20_58544022_length(transcript)=2826nt_BP=336nt GAGCCATTGATTGGTCGACGCCCCCAGAGGGTTACAATTCAAACGCGGGCGGGCGGGCCCGCAGTCCTGCAGTTGCAGTCGTGTTCTCCG AGTTCCTGTCTCTCTGCCAACGCCGCCCGGATGGCTTCCCAAAACCGCGACCCAGCCGCCACTAGCGTCGCCGCCGCCCGTAAAGGAGCT GAGCCGAGCGGGGGCGCCGCCCGGGGTCCGGTGGGCAAAAGGCTACAGCAGGAGCTGATGACCCTCATGATGTCTGGCGATAAAGGGATT TCTGCCTTCCCTGAATCAGACAACCTTTTCAAATGGGTAGGGACCATCCATGGAGCAGCTGGAACAGTCAGTATCATTGACAGTGTTCAA CAGGAAACAGATGATCTTACTAAGCAAACAAAGGAAAAGATCTACCAGCCTCTACGGCGATCCAAGAGAAGATGGGTTATCACCACCTTG GAGCTGGAGGAGGAAGACCCGGGACCCTTTCCCAAACTCATTGGTGAGCTGTTCAATAATATGTCTTATAACATGTCACTAATGTATCTA ATCAGTGGACCTGGTGTGGATGAATATCCAGAGATTGGTTTGTTTTCTCTAGAAGATCATGAGAACGGAAGGATATATGTTCACCGCCCT GTCGATCGAGAAATGACACCATCTTTCACGGTTTATTTTGATGTTGTGGAGCGCTCAACAGGAAAAATTGTGGATACATCCTTGATTTTC AACATTAGGATCAGTGATGTGAATGATCATGCACCCCAGTTTCCAGAGAAGGAATTTAACATCACTGTGCAAGAAAACCAATCTGCAGGG CAACCTATTTTTCAGATGTTAGCAGTCGATTTGGATGAAGAAAACACTCCAAATTCTCAAGTCCTTTACTTCCTCATTTCTCAAACACCA TTACTGAAAGAAAGTGGTTTCCGGGTTGATCGCCTTAGTGGAGAAATACGACTCTCTGGCTGCTTAGATTATGAGACCGCTCCTCAGTTT ACACTGCTAATCAGAGCCAGGGACTGTGGAGAACCGTCACTGTCATCCACGACCACCGTTCACGTGGATGTGCAAGAAGGCAACAACCAC AGGCCTGCATTTACCCAGGAGAACTATAAGGTTCAGATTCCTGAAGGCCGAGCCAGCCAGGGCGTGTTGCGTCTCCTGGTTCAAGATCGA GATTCTCCATTTACATCAGCTTGGAGAGCAAAATTCAACATATTGCATGGCAATGAAGAGGGGCATTTTGACATTTCGACTGACCCTGAG ACCAACGAAGGGATATTAAATGTTATCAAGCCTTTGGATTATGAGACTCGCCCAGCGCAAAGCCTCATCATTGTCGTGGAGAATGAGGAG AGGCTCGTCTTCTGTGAGAGAGGAAAGCTTCAGCCGCCAAGGAAGGCAGCAGCCAGCGCCACTGTGAGTGTGCAGGTGACAGACGCCAAC GACCCACCAGCCTTTCACCCCCAGAGCTTCATTGTCAATAAAGAGGAGGGCGCCAGGCCTGGGACCCTGTTGGGAACTTTTAATGCCATG GATCCAGACAGCCAGATAAGATATGAACTGGTTCATGACCCAGCAAATTGGGTCAGCGTCGACAAAAACTCCGGAGTGGTCATCACCGTG GAGCCAATTGACCGAGAATCCCCTCATGTAAATAACAGTTTTTATGTAATCATCATTCACGCTGTTGATGATGGCTTCCCACCGCAGACT GCTACAGGGACCCTAATGCTCTTCCTGTCTGACATCAATGACAACGTCCCGACTCTCCGGCCACGTTCCCGCTACATGGAGGTCTGTGAG TCTGCTGTGCATGAGCCCCTCCACATCGAGGCAGAGGATCCGGACCTGGAGCCGTTCTCTGACCCATTTACATTTGAATTGGACAATACC TGGGGAAATGCGGAGGACACATGGAAGTTGGGGAGAAATTGGGGTCAATCAGTTGAACTTTTAACCTTGAGAAGCCTGCCACGTGGTAAT TACTTGGTGCCACTCTTCATTGGAGACAAACAGGGACTTTCCCAGAAGCAAACTGTCCATGTAAGGATCTGCCCCTGTGCCAGTGGGCTC ACATGTGTGGAGCTTGCAGATGCAGAAGTGGGGCTTCATGTGGGGGCCCTGTTCCCTGTCTGTGCAGCATTTGTGGCTCTGGCAGTGGCT CTGCTTTTTCTGTTGCGATGCTATTTTGTGCTTGAACCTAAGAGGCATGGATGCTCTGTATCCAATGATGAAGGCCACCAAACACTGGTC ATGTATAATGCGGAGAGCAAAGGCACTTCAGCCCAGACATGGTCAGATGTTGAAGGCCAGAGGCCGGCTCTGCTCATCTGCACAGCTGCA GCAGGACCCACGCAGGGAGTTAAGGCTTACCCAGATGCCACAATGCACAGACAACTCCTGGCTCCGGTGGAAGGAAGGATGGCAGAGACA TTGAATCAGTCTAAAGAGAGAAATCGCTTCAGCCTCAGCAGGGGCTGCATCATCCCCCAGGGAAGAGCCACAGCTGGGCGAGGATTGCCA CAAGACATTTACAAGGAGATGATGCCACGGAGACTAACGCAGACTGGTAAACGGAAACACGGGGCTTTGGCTCGAACACCCTCTTTCAAG AAAGTTGTTTATGACCACAAGGAAGATGAGGAGAACAAGGCTGGGAGAAAGCAAAGGAGCCACTTGTTTAAGGTTATGCAGCTGAGAAAT GAACAAGGTGGGGTTCGAGTCCAGAGTGCGCATTCCCCATCACCCCTTAACAAAAAGGCATGTTTCCCAGGAGACTACAGAGGAGAATCG >In-frame_ENST00000356455_ENST00000244047_TCGA-AN-A0FY-01A_UBE2C_chr20_44443109_+_CDH26_chr20_58544022_length(amino acids)=939AA_start in transcript=6_stop in transcript=2825 MIGRRPQRVTIQTRAGGPAVLQLQSCSPSSCLSANAARMASQNRDPAATSVAAARKGAEPSGGAARGPVGKRLQQELMTLMMSGDKGISA FPESDNLFKWVGTIHGAAGTVSIIDSVQQETDDLTKQTKEKIYQPLRRSKRRWVITTLELEEEDPGPFPKLIGELFNNMSYNMSLMYLIS GPGVDEYPEIGLFSLEDHENGRIYVHRPVDREMTPSFTVYFDVVERSTGKIVDTSLIFNIRISDVNDHAPQFPEKEFNITVQENQSAGQP IFQMLAVDLDEENTPNSQVLYFLISQTPLLKESGFRVDRLSGEIRLSGCLDYETAPQFTLLIRARDCGEPSLSSTTTVHVDVQEGNNHRP AFTQENYKVQIPEGRASQGVLRLLVQDRDSPFTSAWRAKFNILHGNEEGHFDISTDPETNEGILNVIKPLDYETRPAQSLIIVVENEERL VFCERGKLQPPRKAAASATVSVQVTDANDPPAFHPQSFIVNKEEGARPGTLLGTFNAMDPDSQIRYELVHDPANWVSVDKNSGVVITVEP IDRESPHVNNSFYVIIIHAVDDGFPPQTATGTLMLFLSDINDNVPTLRPRSRYMEVCESAVHEPLHIEAEDPDLEPFSDPFTFELDNTWG NAEDTWKLGRNWGQSVELLTLRSLPRGNYLVPLFIGDKQGLSQKQTVHVRICPCASGLTCVELADAEVGLHVGALFPVCAAFVALAVALL FLLRCYFVLEPKRHGCSVSNDEGHQTLVMYNAESKGTSAQTWSDVEGQRPALLICTAAAGPTQGVKAYPDATMHRQLLAPVEGRMAETLN QSKERNRFSLSRGCIIPQGRATAGRGLPQDIYKEMMPRRLTQTGKRKHGALARTPSFKKVVYDHKEDEENKAGRKQRSHLFKVMQLRNEQ -------------------------------------------------------------- >In-frame_ENST00000405520_ENST00000244047_TCGA-AN-A0FY-01A_UBE2C_chr20_44443109_+_CDH26_chr20_58544022_length(transcript)=3426nt_BP=936nt AAACGCGGGCGGGCGGGCCCGCAGTCCTGCAGTTGCAGTCGTGTTCTCCGAGTTCCTGTCTCTCTGCCAACGCCGCCCGGATGGCTTCCC AAAACCGCGACCCAGCCGCCACTAGCGTCGCCGCCGCCCGTAAAGGAGCTGAGCCGAGCGGGGGCGCCGCCCGGGGTCCGGTGGGCAAAA GGTGAGTGATGCGGCCTACCACTCGCCGGGCCTGCCATGCCCTAGGCATTGGTACCCAGAGCAAAGATTTCTAGGACCACCCCCCGCCGC CACCTCCTGGAGCGGGAGATCTGCGGGTGCAGGAGAACACACCAGGAGCTCGGGGCCTGGCATTCCCCTGGGCATGGGTGTCGAGGGCGG AGACTTCCGGGACTCCCACCTCCTTGCGCGGGTGAGATTCGAGAGATGGGGGACAGGCCAGGAGCTCAGACCGCTCTTTGAGACTCTCCC GAAGGAGAATGGGAGGGTAGGGGCGCTGCCAGACTCCTTCCCTGGTGGGCCTAGATGAAGACGCTCAAGGACCCTCGTGACTTGGCCGAG ACAGGGGAAGGGAGAAGTTGAGTCGGGCAAGGAAGAGATGCTAAAGCCTGGGGAATTAAGAACATGCCAGAATCATCCCGAGGGAGTCTG GAATTAGGGAGGGTGAGGACTCGCTAGGATCGTCCTGTGGATCTGGTGAGTATACCCTGAGCTGAGCCTGACCTTGGTGATGTGGGGAGC CTCCATGACGGCTCCCCCTGAGATTCAGGTGGGAGAAGATGCACCGTCTGGAGGCCTGGCCCATCCAGACTCCCAGGTAACCCCGAATAC TCTTTTTTCAGGCTACAGCAGGAGCTGATGACCCTCATGATGTCTGGCGATAAAGGGATTTCTGCCTTCCCTGAATCAGACAACCTTTTC AAATGGGTAGGGACCATCCATGGAGCAGCTGGAACAGTCAGTATCATTGACAGTGTTCAACAGGAAACAGATGATCTTACTAAGCAAACA AAGGAAAAGATCTACCAGCCTCTACGGCGATCCAAGAGAAGATGGGTTATCACCACCTTGGAGCTGGAGGAGGAAGACCCGGGACCCTTT CCCAAACTCATTGGTGAGCTGTTCAATAATATGTCTTATAACATGTCACTAATGTATCTAATCAGTGGACCTGGTGTGGATGAATATCCA GAGATTGGTTTGTTTTCTCTAGAAGATCATGAGAACGGAAGGATATATGTTCACCGCCCTGTCGATCGAGAAATGACACCATCTTTCACG GTTTATTTTGATGTTGTGGAGCGCTCAACAGGAAAAATTGTGGATACATCCTTGATTTTCAACATTAGGATCAGTGATGTGAATGATCAT GCACCCCAGTTTCCAGAGAAGGAATTTAACATCACTGTGCAAGAAAACCAATCTGCAGGGCAACCTATTTTTCAGATGTTAGCAGTCGAT TTGGATGAAGAAAACACTCCAAATTCTCAAGTCCTTTACTTCCTCATTTCTCAAACACCATTACTGAAAGAAAGTGGTTTCCGGGTTGAT CGCCTTAGTGGAGAAATACGACTCTCTGGCTGCTTAGATTATGAGACCGCTCCTCAGTTTACACTGCTAATCAGAGCCAGGGACTGTGGA GAACCGTCACTGTCATCCACGACCACCGTTCACGTGGATGTGCAAGAAGGCAACAACCACAGGCCTGCATTTACCCAGGAGAACTATAAG GTTCAGATTCCTGAAGGCCGAGCCAGCCAGGGCGTGTTGCGTCTCCTGGTTCAAGATCGAGATTCTCCATTTACATCAGCTTGGAGAGCA AAATTCAACATATTGCATGGCAATGAAGAGGGGCATTTTGACATTTCGACTGACCCTGAGACCAACGAAGGGATATTAAATGTTATCAAG CCTTTGGATTATGAGACTCGCCCAGCGCAAAGCCTCATCATTGTCGTGGAGAATGAGGAGAGGCTCGTCTTCTGTGAGAGAGGAAAGCTT CAGCCGCCAAGGAAGGCAGCAGCCAGCGCCACTGTGAGTGTGCAGGTGACAGACGCCAACGACCCACCAGCCTTTCACCCCCAGAGCTTC ATTGTCAATAAAGAGGAGGGCGCCAGGCCTGGGACCCTGTTGGGAACTTTTAATGCCATGGATCCAGACAGCCAGATAAGATATGAACTG GTTCATGACCCAGCAAATTGGGTCAGCGTCGACAAAAACTCCGGAGTGGTCATCACCGTGGAGCCAATTGACCGAGAATCCCCTCATGTA AATAACAGTTTTTATGTAATCATCATTCACGCTGTTGATGATGGCTTCCCACCGCAGACTGCTACAGGGACCCTAATGCTCTTCCTGTCT GACATCAATGACAACGTCCCGACTCTCCGGCCACGTTCCCGCTACATGGAGGTCTGTGAGTCTGCTGTGCATGAGCCCCTCCACATCGAG GCAGAGGATCCGGACCTGGAGCCGTTCTCTGACCCATTTACATTTGAATTGGACAATACCTGGGGAAATGCGGAGGACACATGGAAGTTG GGGAGAAATTGGGGTCAATCAGTTGAACTTTTAACCTTGAGAAGCCTGCCACGTGGTAATTACTTGGTGCCACTCTTCATTGGAGACAAA CAGGGACTTTCCCAGAAGCAAACTGTCCATGTAAGGATCTGCCCCTGTGCCAGTGGGCTCACATGTGTGGAGCTTGCAGATGCAGAAGTG GGGCTTCATGTGGGGGCCCTGTTCCCTGTCTGTGCAGCATTTGTGGCTCTGGCAGTGGCTCTGCTTTTTCTGTTGCGATGCTATTTTGTG CTTGAACCTAAGAGGCATGGATGCTCTGTATCCAATGATGAAGGCCACCAAACACTGGTCATGTATAATGCGGAGAGCAAAGGCACTTCA GCCCAGACATGGTCAGATGTTGAAGGCCAGAGGCCGGCTCTGCTCATCTGCACAGCTGCAGCAGGACCCACGCAGGGAGTTAAGGCTTAC CCAGATGCCACAATGCACAGACAACTCCTGGCTCCGGTGGAAGGAAGGATGGCAGAGACATTGAATCAGTCTAAAGAGAGAAATCGCTTC AGCCTCAGCAGGGGCTGCATCATCCCCCAGGGAAGAGCCACAGCTGGGCGAGGATTGCCACAAGACATTTACAAGGAGATGATGCCACGG AGACTAACGCAGACTGGTAAACGGAAACACGGGGCTTTGGCTCGAACACCCTCTTTCAAGAAAGTTGTTTATGACCACAAGGAAGATGAG GAGAACAAGGCTGGGAGAAAGCAAAGGAGCCACTTGTTTAAGGTTATGCAGCTGAGAAATGAACAAGGTGGGGTTCGAGTCCAGAGTGCG CATTCCCCATCACCCCTTAACAAAAAGGCATGTTTCCCAGGAGACTACAGAGGAGAATCGGCAGGTGGTCACAATTGCAGGGCTGTCTCA >In-frame_ENST00000405520_ENST00000244047_TCGA-AN-A0FY-01A_UBE2C_chr20_44443109_+_CDH26_chr20_58544022_length(amino acids)=863AA_start in transcript=834_stop in transcript=3425 MMTLMMSGDKGISAFPESDNLFKWVGTIHGAAGTVSIIDSVQQETDDLTKQTKEKIYQPLRRSKRRWVITTLELEEEDPGPFPKLIGELF NNMSYNMSLMYLISGPGVDEYPEIGLFSLEDHENGRIYVHRPVDREMTPSFTVYFDVVERSTGKIVDTSLIFNIRISDVNDHAPQFPEKE FNITVQENQSAGQPIFQMLAVDLDEENTPNSQVLYFLISQTPLLKESGFRVDRLSGEIRLSGCLDYETAPQFTLLIRARDCGEPSLSSTT TVHVDVQEGNNHRPAFTQENYKVQIPEGRASQGVLRLLVQDRDSPFTSAWRAKFNILHGNEEGHFDISTDPETNEGILNVIKPLDYETRP AQSLIIVVENEERLVFCERGKLQPPRKAAASATVSVQVTDANDPPAFHPQSFIVNKEEGARPGTLLGTFNAMDPDSQIRYELVHDPANWV SVDKNSGVVITVEPIDRESPHVNNSFYVIIIHAVDDGFPPQTATGTLMLFLSDINDNVPTLRPRSRYMEVCESAVHEPLHIEAEDPDLEP FSDPFTFELDNTWGNAEDTWKLGRNWGQSVELLTLRSLPRGNYLVPLFIGDKQGLSQKQTVHVRICPCASGLTCVELADAEVGLHVGALF PVCAAFVALAVALLFLLRCYFVLEPKRHGCSVSNDEGHQTLVMYNAESKGTSAQTWSDVEGQRPALLICTAAAGPTQGVKAYPDATMHRQ LLAPVEGRMAETLNQSKERNRFSLSRGCIIPQGRATAGRGLPQDIYKEMMPRRLTQTGKRKHGALARTPSFKKVVYDHKEDEENKAGRKQ -------------------------------------------------------------- >In-frame_ENST00000335046_ENST00000244047_TCGA-AN-A0FY-01A_UBE2C_chr20_44443109_+_CDH26_chr20_58544022_length(transcript)=2767nt_BP=277nt CGCAGTCCTGCAGTTGCAGTCGTGTTCTCCGAGTTCCTGTCTCTCTGCCAACGCCGCCCGGATGGCTTCCCAAAACCGCGACCCAGCCGC CACTAGCGTCGCCGCCGCCCGTAAAGGAGCTGAGCCGAGCGGGGGCGCCGCCCGGGGTCCGGTGGGCAAAAGGCTACAGCAGGAGCTGAT GACCCTCATGATGTCTGGCGATAAAGGGATTTCTGCCTTCCCTGAATCAGACAACCTTTTCAAATGGGTAGGGACCATCCATGGAGCAGC TGGAACAGTCAGTATCATTGACAGTGTTCAACAGGAAACAGATGATCTTACTAAGCAAACAAAGGAAAAGATCTACCAGCCTCTACGGCG ATCCAAGAGAAGATGGGTTATCACCACCTTGGAGCTGGAGGAGGAAGACCCGGGACCCTTTCCCAAACTCATTGGTGAGCTGTTCAATAA TATGTCTTATAACATGTCACTAATGTATCTAATCAGTGGACCTGGTGTGGATGAATATCCAGAGATTGGTTTGTTTTCTCTAGAAGATCA TGAGAACGGAAGGATATATGTTCACCGCCCTGTCGATCGAGAAATGACACCATCTTTCACGGTTTATTTTGATGTTGTGGAGCGCTCAAC AGGAAAAATTGTGGATACATCCTTGATTTTCAACATTAGGATCAGTGATGTGAATGATCATGCACCCCAGTTTCCAGAGAAGGAATTTAA CATCACTGTGCAAGAAAACCAATCTGCAGGGCAACCTATTTTTCAGATGTTAGCAGTCGATTTGGATGAAGAAAACACTCCAAATTCTCA AGTCCTTTACTTCCTCATTTCTCAAACACCATTACTGAAAGAAAGTGGTTTCCGGGTTGATCGCCTTAGTGGAGAAATACGACTCTCTGG CTGCTTAGATTATGAGACCGCTCCTCAGTTTACACTGCTAATCAGAGCCAGGGACTGTGGAGAACCGTCACTGTCATCCACGACCACCGT TCACGTGGATGTGCAAGAAGGCAACAACCACAGGCCTGCATTTACCCAGGAGAACTATAAGGTTCAGATTCCTGAAGGCCGAGCCAGCCA GGGCGTGTTGCGTCTCCTGGTTCAAGATCGAGATTCTCCATTTACATCAGCTTGGAGAGCAAAATTCAACATATTGCATGGCAATGAAGA GGGGCATTTTGACATTTCGACTGACCCTGAGACCAACGAAGGGATATTAAATGTTATCAAGCCTTTGGATTATGAGACTCGCCCAGCGCA AAGCCTCATCATTGTCGTGGAGAATGAGGAGAGGCTCGTCTTCTGTGAGAGAGGAAAGCTTCAGCCGCCAAGGAAGGCAGCAGCCAGCGC CACTGTGAGTGTGCAGGTGACAGACGCCAACGACCCACCAGCCTTTCACCCCCAGAGCTTCATTGTCAATAAAGAGGAGGGCGCCAGGCC TGGGACCCTGTTGGGAACTTTTAATGCCATGGATCCAGACAGCCAGATAAGATATGAACTGGTTCATGACCCAGCAAATTGGGTCAGCGT CGACAAAAACTCCGGAGTGGTCATCACCGTGGAGCCAATTGACCGAGAATCCCCTCATGTAAATAACAGTTTTTATGTAATCATCATTCA CGCTGTTGATGATGGCTTCCCACCGCAGACTGCTACAGGGACCCTAATGCTCTTCCTGTCTGACATCAATGACAACGTCCCGACTCTCCG GCCACGTTCCCGCTACATGGAGGTCTGTGAGTCTGCTGTGCATGAGCCCCTCCACATCGAGGCAGAGGATCCGGACCTGGAGCCGTTCTC TGACCCATTTACATTTGAATTGGACAATACCTGGGGAAATGCGGAGGACACATGGAAGTTGGGGAGAAATTGGGGTCAATCAGTTGAACT TTTAACCTTGAGAAGCCTGCCACGTGGTAATTACTTGGTGCCACTCTTCATTGGAGACAAACAGGGACTTTCCCAGAAGCAAACTGTCCA TGTAAGGATCTGCCCCTGTGCCAGTGGGCTCACATGTGTGGAGCTTGCAGATGCAGAAGTGGGGCTTCATGTGGGGGCCCTGTTCCCTGT CTGTGCAGCATTTGTGGCTCTGGCAGTGGCTCTGCTTTTTCTGTTGCGATGCTATTTTGTGCTTGAACCTAAGAGGCATGGATGCTCTGT ATCCAATGATGAAGGCCACCAAACACTGGTCATGTATAATGCGGAGAGCAAAGGCACTTCAGCCCAGACATGGTCAGATGTTGAAGGCCA GAGGCCGGCTCTGCTCATCTGCACAGCTGCAGCAGGACCCACGCAGGGAGTTAAGGCTTACCCAGATGCCACAATGCACAGACAACTCCT GGCTCCGGTGGAAGGAAGGATGGCAGAGACATTGAATCAGTCTAAAGAGAGAAATCGCTTCAGCCTCAGCAGGGGCTGCATCATCCCCCA GGGAAGAGCCACAGCTGGGCGAGGATTGCCACAAGACATTTACAAGGAGATGATGCCACGGAGACTAACGCAGACTGGTAAACGGAAACA CGGGGCTTTGGCTCGAACACCCTCTTTCAAGAAAGTTGTTTATGACCACAAGGAAGATGAGGAGAACAAGGCTGGGAGAAAGCAAAGGAG CCACTTGTTTAAGGTTATGCAGCTGAGAAATGAACAAGGTGGGGTTCGAGTCCAGAGTGCGCATTCCCCATCACCCCTTAACAAAAAGGC >In-frame_ENST00000335046_ENST00000244047_TCGA-AN-A0FY-01A_UBE2C_chr20_44443109_+_CDH26_chr20_58544022_length(amino acids)=920AA_start in transcript=7_stop in transcript=2766 MQLQSCSPSSCLSANAARMASQNRDPAATSVAAARKGAEPSGGAARGPVGKRLQQELMTLMMSGDKGISAFPESDNLFKWVGTIHGAAGT VSIIDSVQQETDDLTKQTKEKIYQPLRRSKRRWVITTLELEEEDPGPFPKLIGELFNNMSYNMSLMYLISGPGVDEYPEIGLFSLEDHEN GRIYVHRPVDREMTPSFTVYFDVVERSTGKIVDTSLIFNIRISDVNDHAPQFPEKEFNITVQENQSAGQPIFQMLAVDLDEENTPNSQVL YFLISQTPLLKESGFRVDRLSGEIRLSGCLDYETAPQFTLLIRARDCGEPSLSSTTTVHVDVQEGNNHRPAFTQENYKVQIPEGRASQGV LRLLVQDRDSPFTSAWRAKFNILHGNEEGHFDISTDPETNEGILNVIKPLDYETRPAQSLIIVVENEERLVFCERGKLQPPRKAAASATV SVQVTDANDPPAFHPQSFIVNKEEGARPGTLLGTFNAMDPDSQIRYELVHDPANWVSVDKNSGVVITVEPIDRESPHVNNSFYVIIIHAV DDGFPPQTATGTLMLFLSDINDNVPTLRPRSRYMEVCESAVHEPLHIEAEDPDLEPFSDPFTFELDNTWGNAEDTWKLGRNWGQSVELLT LRSLPRGNYLVPLFIGDKQGLSQKQTVHVRICPCASGLTCVELADAEVGLHVGALFPVCAAFVALAVALLFLLRCYFVLEPKRHGCSVSN DEGHQTLVMYNAESKGTSAQTWSDVEGQRPALLICTAAAGPTQGVKAYPDATMHRQLLAPVEGRMAETLNQSKERNRFSLSRGCIIPQGR ATAGRGLPQDIYKEMMPRRLTQTGKRKHGALARTPSFKKVVYDHKEDEENKAGRKQRSHLFKVMQLRNEQGGVRVQSAHSPSPLNKKACF -------------------------------------------------------------- >In-frame_ENST00000372568_ENST00000244047_TCGA-AN-A0FY-01A_UBE2C_chr20_44443109_+_CDH26_chr20_58544022_length(transcript)=2890nt_BP=400nt GGTGAGATTCGAGAGATGGGGGACAGGCCAGGAGCTCAGACCGCTCTTTGAGACTCTCCCGAAGGAGAATGGGAGGGTAGGGGCGCTGCC AGACTCCTTCCCTGGTGGGCCTAGATGAAGACGCTCAAGGACCCTCGTGACTTGGCCGAGACAGGGGAAGGGAGAAGTTGAGTCGGGCAA GGAAGAGATGCTAAAGCCTGGGGAATTAAGAACATGCCAGAATCATCCCGAGGGAGTCTGGAATTAGGGAGGGTGAGGACTCGCTAGGAT CGTCCTGTGGATCTGGCTACAGCAGGAGCTGATGACCCTCATGATGTCTGGCGATAAAGGGATTTCTGCCTTCCCTGAATCAGACAACCT TTTCAAATGGGTAGGGACCATCCATGGAGCAGCTGGAACAGTCAGTATCATTGACAGTGTTCAACAGGAAACAGATGATCTTACTAAGCA AACAAAGGAAAAGATCTACCAGCCTCTACGGCGATCCAAGAGAAGATGGGTTATCACCACCTTGGAGCTGGAGGAGGAAGACCCGGGACC CTTTCCCAAACTCATTGGTGAGCTGTTCAATAATATGTCTTATAACATGTCACTAATGTATCTAATCAGTGGACCTGGTGTGGATGAATA TCCAGAGATTGGTTTGTTTTCTCTAGAAGATCATGAGAACGGAAGGATATATGTTCACCGCCCTGTCGATCGAGAAATGACACCATCTTT CACGGTTTATTTTGATGTTGTGGAGCGCTCAACAGGAAAAATTGTGGATACATCCTTGATTTTCAACATTAGGATCAGTGATGTGAATGA TCATGCACCCCAGTTTCCAGAGAAGGAATTTAACATCACTGTGCAAGAAAACCAATCTGCAGGGCAACCTATTTTTCAGATGTTAGCAGT CGATTTGGATGAAGAAAACACTCCAAATTCTCAAGTCCTTTACTTCCTCATTTCTCAAACACCATTACTGAAAGAAAGTGGTTTCCGGGT TGATCGCCTTAGTGGAGAAATACGACTCTCTGGCTGCTTAGATTATGAGACCGCTCCTCAGTTTACACTGCTAATCAGAGCCAGGGACTG TGGAGAACCGTCACTGTCATCCACGACCACCGTTCACGTGGATGTGCAAGAAGGCAACAACCACAGGCCTGCATTTACCCAGGAGAACTA TAAGGTTCAGATTCCTGAAGGCCGAGCCAGCCAGGGCGTGTTGCGTCTCCTGGTTCAAGATCGAGATTCTCCATTTACATCAGCTTGGAG AGCAAAATTCAACATATTGCATGGCAATGAAGAGGGGCATTTTGACATTTCGACTGACCCTGAGACCAACGAAGGGATATTAAATGTTAT CAAGCCTTTGGATTATGAGACTCGCCCAGCGCAAAGCCTCATCATTGTCGTGGAGAATGAGGAGAGGCTCGTCTTCTGTGAGAGAGGAAA GCTTCAGCCGCCAAGGAAGGCAGCAGCCAGCGCCACTGTGAGTGTGCAGGTGACAGACGCCAACGACCCACCAGCCTTTCACCCCCAGAG CTTCATTGTCAATAAAGAGGAGGGCGCCAGGCCTGGGACCCTGTTGGGAACTTTTAATGCCATGGATCCAGACAGCCAGATAAGATATGA ACTGGTTCATGACCCAGCAAATTGGGTCAGCGTCGACAAAAACTCCGGAGTGGTCATCACCGTGGAGCCAATTGACCGAGAATCCCCTCA TGTAAATAACAGTTTTTATGTAATCATCATTCACGCTGTTGATGATGGCTTCCCACCGCAGACTGCTACAGGGACCCTAATGCTCTTCCT GTCTGACATCAATGACAACGTCCCGACTCTCCGGCCACGTTCCCGCTACATGGAGGTCTGTGAGTCTGCTGTGCATGAGCCCCTCCACAT CGAGGCAGAGGATCCGGACCTGGAGCCGTTCTCTGACCCATTTACATTTGAATTGGACAATACCTGGGGAAATGCGGAGGACACATGGAA GTTGGGGAGAAATTGGGGTCAATCAGTTGAACTTTTAACCTTGAGAAGCCTGCCACGTGGTAATTACTTGGTGCCACTCTTCATTGGAGA CAAACAGGGACTTTCCCAGAAGCAAACTGTCCATGTAAGGATCTGCCCCTGTGCCAGTGGGCTCACATGTGTGGAGCTTGCAGATGCAGA AGTGGGGCTTCATGTGGGGGCCCTGTTCCCTGTCTGTGCAGCATTTGTGGCTCTGGCAGTGGCTCTGCTTTTTCTGTTGCGATGCTATTT TGTGCTTGAACCTAAGAGGCATGGATGCTCTGTATCCAATGATGAAGGCCACCAAACACTGGTCATGTATAATGCGGAGAGCAAAGGCAC TTCAGCCCAGACATGGTCAGATGTTGAAGGCCAGAGGCCGGCTCTGCTCATCTGCACAGCTGCAGCAGGACCCACGCAGGGAGTTAAGGC TTACCCAGATGCCACAATGCACAGACAACTCCTGGCTCCGGTGGAAGGAAGGATGGCAGAGACATTGAATCAGTCTAAAGAGAGAAATCG CTTCAGCCTCAGCAGGGGCTGCATCATCCCCCAGGGAAGAGCCACAGCTGGGCGAGGATTGCCACAAGACATTTACAAGGAGATGATGCC ACGGAGACTAACGCAGACTGGTAAACGGAAACACGGGGCTTTGGCTCGAACACCCTCTTTCAAGAAAGTTGTTTATGACCACAAGGAAGA TGAGGAGAACAAGGCTGGGAGAAAGCAAAGGAGCCACTTGTTTAAGGTTATGCAGCTGAGAAATGAACAAGGTGGGGTTCGAGTCCAGAG TGCGCATTCCCCATCACCCCTTAACAAAAAGGCATGTTTCCCAGGAGACTACAGAGGAGAATCGGCAGGTGGTCACAATTGCAGGGCTGT >In-frame_ENST00000372568_ENST00000244047_TCGA-AN-A0FY-01A_UBE2C_chr20_44443109_+_CDH26_chr20_58544022_length(amino acids)=872AA_start in transcript=274_stop in transcript=2889 MWIWLQQELMTLMMSGDKGISAFPESDNLFKWVGTIHGAAGTVSIIDSVQQETDDLTKQTKEKIYQPLRRSKRRWVITTLELEEEDPGPF PKLIGELFNNMSYNMSLMYLISGPGVDEYPEIGLFSLEDHENGRIYVHRPVDREMTPSFTVYFDVVERSTGKIVDTSLIFNIRISDVNDH APQFPEKEFNITVQENQSAGQPIFQMLAVDLDEENTPNSQVLYFLISQTPLLKESGFRVDRLSGEIRLSGCLDYETAPQFTLLIRARDCG EPSLSSTTTVHVDVQEGNNHRPAFTQENYKVQIPEGRASQGVLRLLVQDRDSPFTSAWRAKFNILHGNEEGHFDISTDPETNEGILNVIK PLDYETRPAQSLIIVVENEERLVFCERGKLQPPRKAAASATVSVQVTDANDPPAFHPQSFIVNKEEGARPGTLLGTFNAMDPDSQIRYEL VHDPANWVSVDKNSGVVITVEPIDRESPHVNNSFYVIIIHAVDDGFPPQTATGTLMLFLSDINDNVPTLRPRSRYMEVCESAVHEPLHIE AEDPDLEPFSDPFTFELDNTWGNAEDTWKLGRNWGQSVELLTLRSLPRGNYLVPLFIGDKQGLSQKQTVHVRICPCASGLTCVELADAEV GLHVGALFPVCAAFVALAVALLFLLRCYFVLEPKRHGCSVSNDEGHQTLVMYNAESKGTSAQTWSDVEGQRPALLICTAAAGPTQGVKAY PDATMHRQLLAPVEGRMAETLNQSKERNRFSLSRGCIIPQGRATAGRGLPQDIYKEMMPRRLTQTGKRKHGALARTPSFKKVVYDHKEDE -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for UBE2C-CDH26 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for UBE2C-CDH26 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for UBE2C-CDH26 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | UBE2C | C0004403 | Autosome Abnormalities | 1 | CTD_human |
Hgene | UBE2C | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
Hgene | UBE2C | C0008625 | Chromosome Aberrations | 1 | CTD_human |
Hgene | UBE2C | C0678222 | Breast Carcinoma | 1 | CTD_human |
Hgene | UBE2C | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
Hgene | UBE2C | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Hgene | UBE2C | C2239176 | Liver carcinoma | 1 | CTD_human |
Hgene | UBE2C | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |